[go: up one dir, main page]

MX9800483A - Derivados de piperazina y su uso como antagonistas de 5-ht1a. - Google Patents

Derivados de piperazina y su uso como antagonistas de 5-ht1a.

Info

Publication number
MX9800483A
MX9800483A MX9800483A MX9800483A MX9800483A MX 9800483 A MX9800483 A MX 9800483A MX 9800483 A MX9800483 A MX 9800483A MX 9800483 A MX9800483 A MX 9800483A MX 9800483 A MX9800483 A MX 9800483A
Authority
MX
Mexico
Prior art keywords
piperazine derivatives
ht1a antagonists
compound
ht1a
antagonists
Prior art date
Application number
MX9800483A
Other languages
English (en)
Inventor
Andrew Fensome
Michael Gerard Kelly
Howard Langham
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of MX9800483A publication Critical patent/MX9800483A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto de la formula general (A) se describe conjuntamente con sales de adicion de ácido farmacéuticamente aceptables del mismo. El compuesto es un antagonista de 5-HT1A que es util en el tratamiento de desordenes del SNC en mamíferos.
MX9800483A 1995-07-20 1996-07-19 Derivados de piperazina y su uso como antagonistas de 5-ht1a. MX9800483A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9514901.9A GB9514901D0 (en) 1995-07-20 1995-07-20 Piperazine derivatives
PCT/GB1996/001714 WO1997003982A1 (en) 1995-07-20 1996-07-19 Piperazine derivatives and their use as 5-ht1a antagonists

Publications (1)

Publication Number Publication Date
MX9800483A true MX9800483A (es) 1998-04-30

Family

ID=10778004

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9800483A MX9800483A (es) 1995-07-20 1996-07-19 Derivados de piperazina y su uso como antagonistas de 5-ht1a.

Country Status (21)

Country Link
EP (1) EP0839146B1 (es)
JP (1) JP4166824B2 (es)
KR (1) KR100447002B1 (es)
CN (2) CN1077889C (es)
AR (1) AR003451A1 (es)
AT (1) ATE196294T1 (es)
AU (1) AU700546B2 (es)
BR (1) BR9609694A (es)
CA (1) CA2227386C (es)
DE (1) DE69610316T2 (es)
DK (1) DK0839146T3 (es)
ES (1) ES2150684T3 (es)
GB (1) GB9514901D0 (es)
GR (1) GR3034408T3 (es)
HU (1) HUP9802447A3 (es)
IL (1) IL122981A (es)
MX (1) MX9800483A (es)
NZ (1) NZ313231A (es)
PT (1) PT839146E (es)
WO (1) WO1997003982A1 (es)
ZA (1) ZA966048B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19730989A1 (de) * 1997-07-18 1999-01-21 Merck Patent Gmbh Piperazin-Derivate
US6399614B1 (en) 1997-08-01 2002-06-04 Recordati S.A. Chemical And Pharmaceutical Company 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
IT1293804B1 (it) 1997-08-01 1999-03-10 Recordati Chem Pharm Diarilalchilpiperazine attive sulle basse vie urinarie
US6271234B1 (en) * 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
US6469007B2 (en) 2000-11-28 2002-10-22 Wyeth Serotonergic agents
US20060223824A1 (en) 2000-11-28 2006-10-05 Wyeth Serotonergic agents
US20060287335A1 (en) 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
ATE424825T1 (de) 2001-07-20 2009-03-15 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
US6713626B2 (en) * 2002-03-12 2004-03-30 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
US7091349B2 (en) 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
US7361773B2 (en) 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
JP4397693B2 (ja) * 2002-03-12 2010-01-13 ワイス Ｎ１−（２’−ピリジル）−１，２−アルカンジアミンスルファミン酸の合成および生物学的に活性なピペラジンの合成におけるその使用
CA2477906A1 (en) 2002-03-12 2003-09-25 Ivo Jirkovsky Process for making chiral 1,4-disubstituted piperazines
US20050209245A1 (en) * 2004-03-19 2005-09-22 Wyeth Process for preparing N-aryl-piperazine derivatives
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
MX2007015772A (es) 2005-06-17 2008-02-22 Wyeth Corp Compuestos utiles como inhibidores de serotonina y agonistas y antagonistas de 5-ht-1a.
TW200808741A (en) * 2006-06-09 2008-02-16 Wyeth Corp 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
ES2180638T3 (es) * 1994-06-03 2003-02-16 Wyeth John & Brother Ltd Nuevos procedimientos e intermediarios para la preparacion de derivados de piperazina.

Also Published As

Publication number Publication date
KR19990029067A (ko) 1999-04-15
ZA966048B (en) 1998-01-16
AU6524996A (en) 1997-02-18
IL122981A (en) 2001-01-28
HUP9802447A2 (hu) 1999-08-30
IL122981A0 (en) 1998-08-16
GB9514901D0 (en) 1995-09-20
CN1131861C (zh) 2003-12-24
DK0839146T3 (da) 2000-11-20
KR100447002B1 (ko) 2004-12-04
PT839146E (pt) 2000-12-29
CN1077889C (zh) 2002-01-16
EP0839146B1 (en) 2000-09-13
ATE196294T1 (de) 2000-09-15
WO1997003982A1 (en) 1997-02-06
GR3034408T3 (en) 2000-12-29
EP0839146A1 (en) 1998-05-06
AU700546B2 (en) 1999-01-07
CA2227386A1 (en) 1997-02-06
CA2227386C (en) 2006-05-16
JP4166824B2 (ja) 2008-10-15
NZ313231A (en) 2001-03-30
BR9609694A (pt) 1999-03-23
JPH11509544A (ja) 1999-08-24
CN1190968A (zh) 1998-08-19
ES2150684T3 (es) 2000-12-01
HUP9802447A3 (en) 1999-11-29
CN1309127A (zh) 2001-08-22
DE69610316D1 (de) 2000-10-19
AR003451A1 (es) 1998-08-05
DE69610316T2 (de) 2001-03-29

Similar Documents

Publication Publication Date Title
MX9800483A (es) Derivados de piperazina y su uso como antagonistas de 5-ht1a.
GR3034507T3 (en) Pyrazolopyrimidines as crf antagonists.
CA2191871A1 (en) Piperazine derivatives as 5ht1a antagonists
YU52000A (sh) Jedinjenja meta-azaciklične amino benzojeve kiseline i njihovi derivati, koji su antagonisti integrina
YU69902A (sh) Novi derivati piperazina
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
TW359672B (en) Thienopyrimidines ad phosphodiesterase V antagonists, process for the production thereof and pharmaceutical compositions containing the same
IL114894A0 (en) Endothelin antagonists
CA2269815A1 (en) Thienopyrimidines having pde v-inhibiting action
TR200102489T2 (tr) 3-Fenilpiridin Türevleri ve bunların NK-1 alıcı antagonistler olarak kullanılması
NZ514711A (en) Compounds useful as anti-inflammatory agents
ES8801289A1 (es) Un metodo para preparar derivados de cefem
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
CA2134077A1 (en) 4-imidomethyl-1-[2'phenyl-2'oxoethyl-]piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy
ES8607218A1 (es) Un procedimiento para preparar compuestos de amidina
AP1534A (en) Vitronectin receptor antagonists.
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
DE69526452D1 (de) Indolditerpen alkaloide
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
MY108303A (en) Neuroleptic 2-substituted perhydro-1-h-pyrido [1,2-a]pyrazines.
NO950974L (no) Nye N,N,N',N'-tetrasubstituert-1,2-etandiaminderivatforbindelser
MY116365A (en) Process for the preparation of the (-)-n-methyl-n [4-(4-phenyl-4-acetyl-aminopiperidin-1-yl)-2-(3,4-dichlorophenyl) butyl]-benzamide and its pharmaceutically acceptable salts